BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Schwenger KJ, Allard JP. Clinical approaches to non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(7): 1712-1723 [PMID: 24587650 DOI: 10.3748/wjg.v20.i7.1712]
URL: https://www.wjgnet.com/1948-5182/full/v20/i7/1712.htm
Number Citing Articles
1
Takako Mukai, Miki Egawa, Tamaki Takeuchi, Hitoshi Yamashita, Tatsuya Kusudo. Silencing of FABP1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver diseaseFEBS Open Bio 2017; 7(7): 1009 doi: 10.1002/2211-5463.12240
2
Farah Ahsan, Federico Oliveri, Harshit K Goud, Zainab Mehkari, Lubna Mohammed, Moiz Javed, Aldanah Althwanay, Ian H Rutkofsky. Pleiotropic Effects of Statins in the Light of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic SteatohepatitisCureus 2020;  doi: 10.7759/cureus.10446
3
Loek P. Smits, Bram F. Coolen, Maria D. Panno, Jurgen H. Runge, Wouter H. Nijhof, Joanne Verheij, Max Nieuwdorp, Jaap Stoker, Ulrich H. Beuers, Aart J. Nederveen, Erik S. Stroes. Noninvasive Differentiation between Hepatic Steatosis and Steatohepatitis with MR Imaging Enhanced with USPIOs in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept StudyRadiology 2016; 278(3): 782 doi: 10.1148/radiol.2015150952
4
Mahardian Rahmadi, Ahmad Dzulfikri Nurhan, Eka Dewi Pratiwi, Devita Ardina Prameswari, Sisca Melani Panggono, Khoirotin Nisak, Junaidi Khotib. The effect of various high-fat diet on liver histology in the development of NAFLD models in miceJournal of Basic and Clinical Physiology and Pharmacology 2021; 32(4): 547 doi: 10.1515/jbcpp-2020-0426
5
Leila Gobejishvili, Smita Ghare, Rehan Khan, Alexander Cambon, David F. Barker, Shirish Barve, Craig McClain, Daniell Hill. Misoprostol modulates cytokine expression through a cAMP pathway: Potential therapeutic implication for liver diseaseClinical Immunology 2015; 161(2): 291 doi: 10.1016/j.clim.2015.09.008
6
Kazuki Moro, Masayuki Nagahashi, Rajesh Ramanathan, Kazuaki Takabe, Toshifumi Wakai. Resolvins and omega three polyunsaturated fatty acids: Clinical implications in inflammatory diseases and cancerWorld Journal of Clinical Cases 2016; 4(7): 155-164 doi: 10.12998/wjcc.v4.i7.155
7
Jian Li, Zezhou Liu, Mingxing Guo, Kejia Xu, Miao Jiang, Aiping Lu, Xiaoyan Gao. Metabolomics Profiling to Investigate the Pharmacologic Mechanisms of Berberine for the Treatment of High-Fat Diet-Induced Nonalcoholic SteatohepatitisEvidence-Based Complementary and Alternative Medicine 2015; 2015: 1 doi: 10.1155/2015/897914
8
Therapeutic Application of Micellar Solubilized Xanthohumol in a Western-Type Diet-Induced Mouse Model of Obesity, Diabetes and Non-Alcoholic Fatty Liver DiseaseCells 2019; 8(4): 359 doi: 10.3390/cells8040359
9
Virginia Pardo, Águeda González-Rodríguez, Carlos Guijas, Jesús Balsinde, Ángela M. Valverde. Opposite Cross-Talk by Oleate and Palmitate on Insulin Signaling in Hepatocytes through Macrophage ActivationJournal of Biological Chemistry 2015; 290(18): 11663 doi: 10.1074/jbc.M115.649483
10
Xianwen Yuan, Jun Chen, Qi Cheng, Yinjuan Zhao, Pengzi Zhang, Xiaoyan Shao, Yan Bi, Xiaolei Shi, Yitao Ding, Xitai Sun, Bin Xue. Hepatic expression of Yin Yang 1 (YY1) is associated with the non-alcoholic fatty liver disease (NAFLD) progression in patients undergoing bariatric surgeryBMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0871-2
11
A A Svistunov, M A Osadchuk, L I Butorova, G M Tokmulina. Chronic constipation in the practice of a therapist: Features of therapy for comorbidityTerapevticheskii arkhiv 2017; 89(4): 69 doi: 10.17116/terarkh201789469-74
12
Katherine J.P. Schwenger, Sandra E. Fischer, Timothy Jackson, Allan Okrainec, Johane P. Allard. In nonalcoholic fatty liver disease, Roux-en-Y gastric bypass improves liver histology while persistent disease is associated with lower improvements in waist circumference and glycemic controlSurgery for Obesity and Related Diseases 2018; 14(9): 1233 doi: 10.1016/j.soard.2018.06.007
13
Amanda Chaney. Treating the patient with nonalcoholic fatty liver diseaseThe Nurse Practitioner 2015; 40(11): 36 doi: 10.1097/01.NPR.0000472248.28703.18
14
Yu Seol Lee, Jeong Su Park, Da Hyun Lee, Dong-Kyu Lee, Sung Won Kwon, Byung-Wan Lee, Soo Han Bae. The Antidiabetic Drug Lobeglitazone Protects Mice From Lipogenesis-Induced Liver Injury via Mechanistic Target of Rapamycin Complex 1 InhibitionFrontiers in Endocrinology 2018; 9 doi: 10.3389/fendo.2018.00539
15
Olfat M. Hendy, Maha M. Elsabaawy, Mona M. Aref, Fatma M. Khalaf, Abdel Moaty A. Oda, Helmy M. El Shazly. Evaluation of circulating zonulin as a potential marker in the pathogenesis of nonalcoholic fatty liver diseaseAPMIS 2017; 125(7): 607 doi: 10.1111/apm.12696
16
Shu Dong, Zong-Ying Zhan, Hong-Yan Cao, Chao Wu, Yan-Qin Bian, Jian-Yuan Li, Gen-Hong Cheng, Ping Liu, Ming-Yu Sun. Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology 2017; 23(15): 2771-2784 doi: 10.3748/wjg.v23.i15.2771
17
Katherine T. Brunner, Cameron J. Henneberg, Robert M. Wilechansky, Michelle T. Long. Nonalcoholic Fatty Liver Disease and Obesity TreatmentCurrent Obesity Reports 2019; 8(3): 220 doi: 10.1007/s13679-019-00345-1
18
Yukio Osaki, Hiroki Nishikawa. Treatment for hepatocellular carcinoma in J apan over the last three decades: Our experience and published work review Hepatology Research 2015; 45(1): 59 doi: 10.1111/hepr.12378
19
Shuntarou Tsuchiya, Yuichiro Amano, Osamu Isono, Mayumi Imai, Fumi Shimizu, Mari Asada, Shigemitsu Imai, Ayako Harada, Yoshitaka Yasuhara, Ryuichi Tozawa, Hiroshi Nagabukuro. Pharmacological evaluation of pioglitazone and candesartan cilexetil in a novel mouse model of non-alcoholic steatohepatitis, modified choline-deficient, amino acid-defined diet fed low-density lipoprotein receptor knockout miceHepatology Research 2017; 47(6): 584 doi: 10.1111/hepr.12773
20
Peter Dietrich, Claus Hellerbrand. Non-alcoholic fatty liver disease, obesity and the metabolic syndromeBest Practice & Research Clinical Gastroenterology 2014; 28(4): 637 doi: 10.1016/j.bpg.2014.07.008
21
Mohammad Rashidmayvan, Majid Mohammadshahi, Seyed Saeed Seyedian, Mohammad Hossein Haghighizadeh. The effect of Nigella sativa oil on serum levels of inflammatory markers, liver enzymes, lipid profile, insulin and fasting blood sugar in patients with non-alcoholic fatty liverJournal of Diabetes & Metabolic Disorders 2019; 18(2): 453 doi: 10.1007/s40200-019-00439-6
22
Md. Murad Hossain, Abdul Mukheem, Tunku Kamarul. The prevention and treatment of hypoadiponectinemia-associated human diseases by up-regulation of plasma adiponectinLife Sciences 2015; 135: 55 doi: 10.1016/j.lfs.2015.03.010
23
Dina L. Halegoua-De Marzio, Jonathan M. Fenkel. Concepts and Treatment Approaches in Nonalcoholic Fatty Liver DiseaseAdvances in Hepatology 2014; 2014: 1 doi: 10.1155/2014/357965
24
Da Zhou, Qin Pan, Xiao-Lin Liu, Rui-Xu Yang, Yuan-Wen Chen, Chang Liu, Jian-Gao Fan. Clostridium butyricumB1 alleviates high-fat diet-induced steatohepatitis in mice via enterohepatic immunoregulationJournal of Gastroenterology and Hepatology 2017; 32(9): 1640 doi: 10.1111/jgh.13742
25
Roya Navekar, Maryam Rafraf, Aida Ghaffari, Mohammad Asghari-Jafarabadi, Manouchehr Khoshbaten. Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver DiseasesJournal of the American College of Nutrition 2017; 36(4): 261 doi: 10.1080/07315724.2016.1267597
26
Iria Cebreiros López, José Antonio Noguera Velasco. Valoración de la enfermedad por hígado graso no alcohólico desde el laboratorio clínicoRevista del Laboratorio Clínico 2018; 11(3): 163 doi: 10.1016/j.labcli.2017.10.004
27
Montserrat Marí, Albert Morales, Anna Colell, Carmen García-Ruiz, José C. Fernandez-Checa. Studies on Hepatic DisordersOxidative Stress in Applied Basic Research and Clinical Practice 2015; : 279 doi: 10.1007/978-3-319-15539-5_12
28
Qian Li, Steven W. Blume, Joanna C. Huang, Mette Hammer, Michael L. Ganz. Prevalence and healthcare costs of obesity-related comorbidities: evidence from an electronic medical records system in the United StatesJournal of Medical Economics 2015; 18(12): 1020 doi: 10.3111/13696998.2015.1067623
29
Rafael Deminice, Gabriela S. de Castro, Margaret E. Brosnan, John T. Brosnan. Creatine supplementation as a possible new therapeutic approach for fatty liver disease: early findingsAmino Acids 2016; 48(8): 1983 doi: 10.1007/s00726-016-2183-6
30
Parisa Shabani, H Naeimi Khaledi, Maani Beigy, Solaleh Emamgholipour, Eskandar Parvaz, Hossein Poustchi, Mahmood Doosti, Manlio Vinciguerra. Circulating Level of CTRP1 in Patients with Nonalcoholic Fatty Liver Disease (NAFLD): Is It through Insulin Resistance?PLOS ONE 2015; 10(3): e0118650 doi: 10.1371/journal.pone.0118650
31
Shehab M Abd El-Kader, Eman M Salah El-Den Ashmawy. Non-alcoholic fatty liver disease: The diagnosis and managementWorld Journal of Hepatology 2015; 7(6): 846-858 doi: 10.4254/wjh.v7.i6.846
32
Fred F. Poordad. Presentation and complications associated with cirrhosis of the liverCurrent Medical Research and Opinion 2015; 31(5): 925 doi: 10.1185/03007995.2015.1021905
33
C. Bertrand, P. Valet, I. Castan-Laurell. Stéatose et résistance à l’insuline : implication des hépatokinesObésité 2016; 11(3): 170 doi: 10.1007/s11690-015-0492-7
34
Deanna M Salter, Wei Wei, Pragati P Nahar, Emily Marques, Angela L Slitt. Perfluorooctanesulfonic Acid (PFOS) Thwarts the Beneficial Effects of Calorie Restriction and MetforminToxicological Sciences 2021; 182(1): 82 doi: 10.1093/toxsci/kfab043
35
Fabiana de Faria Ghetti, Daiane Gonçalves Oliveira, Juliano Machado de Oliveira, Lincoln Eduardo Villela Vieira de Castro Ferreira, Dionéia Evangelista Cesar, Ana Paula Boroni Moreira. Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitisEuropean Journal of Nutrition 2018; 57(3): 861 doi: 10.1007/s00394-017-1524-x
36
Raquel S. Torrinhas, Dan L. Waitzberg. A Double-blinded Randomized Placebo-controlled Clinical Trial of Omega-3 Fatty Acids for the Treatment of Diabetic Patients With Nonalcoholic SteatohepatitisJournal of Clinical Gastroenterology 2016; 50(2): 180 doi: 10.1097/MCG.0000000000000412
37
Giada Sebastiani, Rasha Alshaalan, Philip Wong, Maria Rubino, Ayat Salman, Peter Metrakos, Marc Deschenes, Peter Ghali, Han-Chieh Lin. Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic SteatohepatitisPLOS ONE 2015; 10(6): e0128774 doi: 10.1371/journal.pone.0128774
38
Giovanni Brandi, Stefania De Lorenzo, Stefania Di Girolamo, Stefano Bellentani, Gioconda Saccoccio, Guido Biasco. Fulminant Hepatitis in a Patient with Hepatocellular Carcinoma Related to Nonalcoholic Steatohepatitis Treated with SorafenibTumori Journal 2015; 101(2): e46 doi: 10.5301/tj.5000247
39
Emanuele Rinninella, Maria Mele, Nicolò Merendino, Marco Cintoni, Gaia Anselmi, Aldo Caporossi, Antonio Gasbarrini, Angelo Minnella. The Role of Diet, Micronutrients and the Gut Microbiota in Age-Related Macular Degeneration: New Perspectives from the Gut–Retina AxisNutrients 2018; 10(11): 1677 doi: 10.3390/nu10111677
40
Farnaz Farsi, Majid Mohammadshahi, Pezhman Alavinejad, Afshin Rezazadeh, Mehdi Zarei, Kambiz Ahmadi Engali. Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical TrialJournal of the American College of Nutrition 2016; 35(4): 346 doi: 10.1080/07315724.2015.1021057
41
Andrey Turchinovich, Ancha Baranova, Oksana Drapkina, Alexander Tonevitsky. Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated DisordersFrontiers in Physiology 2018; 9 doi: 10.3389/fphys.2018.01256
42
Ainara Cano, Cristina Alonso. Deciphering non-alcoholic fatty liver disease through metabolomicsBiochemical Society Transactions 2014; 42(5): 1447 doi: 10.1042/BST20140138
43
Qiaoli Tang, Shan Jiang, Wenjun Jia, Di Shen, Yudong Qiu, Yue Zhao, Bin Xue, Chaojun Li. Zoledronic acid, an FPPS inhibitor, ameliorates liver steatosis through inhibiting hepatic de novo lipogenesisEuropean Journal of Pharmacology 2017; 814: 169 doi: 10.1016/j.ejphar.2017.08.010
44
Amirhossein Sahebkar, Gerard T. Chew, Gerald F. Watts. Recent advances in pharmacotherapy for hypertriglyceridemiaProgress in Lipid Research 2014; 56: 47 doi: 10.1016/j.plipres.2014.07.002
45
Shinhiti Morita, Dalísio De Santi Neto, Flávio Hiroshi Ananias Morita, Nina Kimie Morita, Suzana Margareth Ajeje Lobo. Prevalence of Non-alcoholic Fatty Liver Disease and Steatohepatitis Risk Factors in Patients Undergoing Bariatric SurgeryObesity Surgery 2015; 25(12): 2335 doi: 10.1007/s11695-015-1696-5
46
Azza S. M. Awad, Ekram N. Abd Al Haleem, Wesam M. El-Bakly, Mohie A. Sherief. Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosisNaunyn-Schmiedeberg's Archives of Pharmacology 2016; 389(4): 381 doi: 10.1007/s00210-015-1207-1
47
Biyu Hou, Yuerong Zhao, Guifen Qiang, Xiuying Yang, Chunyang Xu, Xi Chen, Chenge Liu, Xiaobo Wang, Li Zhang, Guanhua Du. Puerarin Mitigates Diabetic Hepatic Steatosis and Fibrosis by Inhibiting TGF-β Signaling Pathway Activation in Type 2 Diabetic RatsOxidative Medicine and Cellular Longevity 2018; 2018: 1 doi: 10.1155/2018/4545321
48
Swaytha Ganesh, Vinod K. Rustgi. Current Pharmacologic Therapy for Nonalcoholic Fatty Liver DiseaseClinics in Liver Disease 2016; 20(2): 351 doi: 10.1016/j.cld.2015.10.009
49
Andrew Jenkinson. Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease2016; : 196 doi: 10.1002/9781118924938.ch22
50
Tannaz Jamialahmadi, Mohsen Nematy, Ali Jangjoo, Ladan Goshayeshi, Mohammed Altigani Abdalla, Saeed Akhlaghi, Thozhukat Sathyapalan, Amirhossein Sahebkar. The predictive role of parathyroid hormone for non-alcoholic fatty liver disease based on invasive and non-invasive findings in candidates of bariatric surgeryEating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity 2021;  doi: 10.1007/s40519-021-01151-2
51
Zhian Sherzad Hayder, Zrar Saleem Kareem. Resistin hormone in diabetic kidney disease and its relation to iron status and hepcidinInternational Urology and Nephrology 2020; 52(4): 749 doi: 10.1007/s11255-020-02434-w
52
Luc F. Van Gaal, Jonathan Mertens, Sven Francque, Christophe De Block. Therapeutic approaches for non-alcoholic steatohepatitisTherapeutic Advances in Endocrinology and Metabolism 2021; 12: 204201882110343 doi: 10.1177/20420188211034300
53
Rohit A. Sinha, Brijesh K. Singh, Paul M. Yen. Thyroid hormone regulation of hepatic lipid and carbohydrate metabolismTrends in Endocrinology & Metabolism 2014; 25(10): 538 doi: 10.1016/j.tem.2014.07.001
54
Juan Esteban Oyarzún, Marcelo E. Andia, Sergio Uribe, Paula Núñez Pizarro, Gabriel Núñez, Gloria Montenegro, Raquel Bridi. Honeybee Pollen Extracts Reduce Oxidative Stress and Steatosis in Hepatic CellsMolecules 2020; 26(1): 6 doi: 10.3390/molecules26010006
55
Elmar Aigner, Alexandra Feldman, Christian Datz. Obesity as an Emerging Risk Factor for Iron DeficiencyNutrients 2014; 6(9): 3587 doi: 10.3390/nu6093587
56
Iria Cebreiros López, Florentina Guzmán Aroca, Maria Dolores Frutos Bernal, Juan Antonio Luján Mompeán, Águeda Bas Bernal, Antonio Miguel Hernández Martínez, Enrique Martínez Barba, Jose Antonio Noguera Velasco, Pascual Parilla Paricio. Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver DiseaseObesity Surgery 2017; 27(9): 2347 doi: 10.1007/s11695-017-2606-9
57
Alex M DePaoli. 20 YEARS OF LEPTIN: Leptin in common obesity and associated disorders of metabolismJournal of Endocrinology 2014; 223(1): T71 doi: 10.1530/JOE-14-0258
58
Minyi Qian, Qianqian Lyu, Yujie Liu, Haiyang Hu, Shilei Wang, Chuyue Pan, Xubin Duan, Yingsheng Gao, Lian-wen Qi, Weizhi Liu, Lirui Wang. Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese MiceMarine Drugs 2019; 17(7): 391 doi: 10.3390/md17070391
59
Mark L. Dreher. Dietary Patterns and Whole Plant Foods in Aging and Disease2018; : 291 doi: 10.1007/978-3-319-59180-3_10
60
Tomohiro Takahashi, Wataru Sugawara, Yuya Takiguchi, Kento Takizawa, Ami Nakabayashi, Mitsuo Nakamura, Michiyo Nagano-Ito, Shinichi Ichikawa. Identification of Plants That Inhibit Lipid Droplet Formation in Liver Cells:Rubus suavissimusLeaf Extract Protects Mice from High-Fat Diet-Induced Fatty Liver by Directly Affecting Liver CellsEvidence-Based Complementary and Alternative Medicine 2016; 2016: 1 doi: 10.1155/2016/4282758
61
Eun Na Han, Eun Sun Cheong, Jeong In Lee, Min Chul Kim, Christopher D. Byrne, Ki-Chul Sung. Change in fatty liver status and 5-year risk of incident metabolic syndrome: a retrospective cohort studyClinical Hypertension 2015; 21(1) doi: 10.1186/s40885-015-0032-7
62
Vishal Patel, Amit Joharapurkar, Samadhan Kshirsagar, Maulik Patel, Brijesh Sutariya, Hiren Patel, Dheerendra Pandey, Dipam Patel, Ramchandra Ranvir, Shekhar Kadam, Rajesh Bahekar, Mukul Jain. Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates nonalcoholic fatty liver diseaseCanadian Journal of Physiology and Pharmacology 2018; 96(6): 587 doi: 10.1139/cjpp-2017-0683
63
Fariborz Mansour-Ghanaei, Makan Pourmasoumi, Amir Hadi, Farahnaz Joukar. Efficacy of curcumin/turmeric on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review of randomized controlled trialsIntegrative Medicine Research 2019; 8(1): 57 doi: 10.1016/j.imr.2018.07.004
64
Dimitrios Papandreou, Eleni Andreou. Role of diet on non-alcoholic fatty liver disease: An updated narrative reviewWorld Journal of Hepatology 2015; 7(3): 575-582 doi: 10.4254/wjh.v7.i3.575
65
Geir Bjørklund, Massimiliano Peana, Lyudmila Pivina, Alexandru Dosa, Jan Aaseth, Yuliya Semenova, Salvatore Chirumbolo, Serenella Medici, Maryam Dadar, Daniel-Ovidiu Costea. Iron Deficiency in Obesity and after Bariatric SurgeryBiomolecules 2021; 11(5): 613 doi: 10.3390/biom11050613
66
Shengtao Zhu, Jihong Shi, Chunpeng Ji, Guang Yang, Jie Xing, Feng Zhu, Liming Lin, Aijun Xing, Zhe Huang, Chenrui Zhu, Xiaoming Wei, Shutian Zhang, Junchao Gu, Shouling Wu. Association of the ideal cardiovascular behaviors and factors with the incidence of nonalcoholic fatty liver diseaseEuropean Journal of Gastroenterology & Hepatology 2018; 30(5): 578 doi: 10.1097/MEG.0000000000001069
67
YAN-GUI WANG, TIAN-LUN YANG. Liraglutide reduces fatty degeneration in hepatic cells via the AMPK/SREBP1 pathwayExperimental and Therapeutic Medicine 2015; 10(5): 1777 doi: 10.3892/etm.2015.2741
68
Jia Liu, Shan Jiang, Yue Zhao, Qian Sun, Jingzi Zhang, Di Shen, Jing Wu, Ning Shen, Xiao Fu, Xitai Sun, Decai Yu, Jun Chen, Jian He, Tingting Shi, Yitao Ding, Lei Fang, Bin Xue, Chaojun Li. Geranylgeranyl diphosphate synthase (GGPPS) regulates non-alcoholic fatty liver disease (NAFLD)-fibrosis progression by determining hepatic glucose/fatty acid preference under high-fat diet conditionsThe Journal of Pathology 2018; 246(3): 277 doi: 10.1002/path.5131
69
Neda Azizi, Mohammad Reza Amini, Kurosh Djafarian, Sakineh Shab-Bidar. The Effects of Nigella sativa Supplementation on Liver Enzymes Levels: a Systematic Review and Meta-analysis of Randomized Controlled TrialsClinical Nutrition Research 2021; 10(1): 72 doi: 10.7762/cnr.2021.10.1.72
70
Brian Finan, Christoffer Clemmensen, Zhimeng Zhu, Kerstin Stemmer, Karine Gauthier, Luisa Müller, Meri De Angelis, Kristin Moreth, Frauke Neff, Diego Perez-Tilve, Katrin Fischer, Dominik Lutter, Miguel A. Sánchez-Garrido, Peng Liu, Jan Tuckermann, Mohsen Malehmir, Marc E. Healy, Achim Weber, Mathias Heikenwalder, Martin Jastroch, Maximilian Kleinert, Sigrid Jall, Sara Brandt, Frédéric Flamant, Karl-Werner Schramm, Heike Biebermann, Yvonne Döring, Christian Weber, Kirk M. Habegger, Michaela Keuper, Vasily Gelfanov, Fa Liu, Josef Köhrle, Jan Rozman, Helmut Fuchs, Valerie Gailus-Durner, Martin Hrabě de Angelis, Susanna M. Hofmann, Bin Yang, Matthias H. Tschöp, Richard DiMarchi, Timo D. Müller. Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic DiseaseCell 2016; 167(3): 843 doi: 10.1016/j.cell.2016.09.014
71
Yilin Song, Lianzhen Zhou, Michael D. Jensen. Errors in measuring plasma free fatty acid concentrations with a popular enzymatic colorimetric kitClinical Biochemistry 2019; 66: 83 doi: 10.1016/j.clinbiochem.2019.01.008
72
Gavin Hamilton, Michael S. Middleton, Elhamy R. Heba, Claude B. Sirlin. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease2019; : 141 doi: 10.1007/978-3-030-11748-1_6
73
Afagh Garjani, Abdolrasoul Safaeiyan, Manouchehr Khoshbaten. Association Between Platelet Count as a Noninvasive Marker and Ultrasonographic Grading in Patients With Nonalcoholic Fatty Liver DiseaseHepatitis Monthly 2015; 15(1) doi: 10.5812/hepatmon.24449
74
Adam Jurgoński, Bartosz Fotschki, Jerzy Juśkiewicz. Disparate metabolic effects of blackcurrant seed oil in rats fed a basal and obesogenic dietEuropean Journal of Nutrition 2015; 54(6): 991 doi: 10.1007/s00394-014-0775-z
75
John E. Lewis, Steven E. Atlas, Oscar L. Higuera, Andrea Fiallo, Ammar Rasul, Ashar Farooqi, Olga Kromo, Laura A. Lantigua, Eduard Tiozzo, Judi M. Woolger, Sharon Goldberg, Armando Mendez, Allan E. Rodriguez, Janet Konefal. The Effect of a Hydrolyzed Polysaccharide Dietary Supplement on Biomarkers in Adults with Nonalcoholic Fatty Liver DiseaseEvidence-Based Complementary and Alternative Medicine 2018; 2018: 1 doi: 10.1155/2018/1751583
76
Carla Lubrano, Giuseppe Valacchi, Palma Specchia, Lucio Gnessi, Elizaveta P. Rubanenko, Elena A. Shuginina, Arseny I. Trukhanov, Liudmila G. Korkina, Chiara De Luca. Integrated Haematological Profiles of RedoxStatus, Lipid, and Inflammatory Protein Biomarkers in Benign Obesity and Unhealthy Obesity with Metabolic SyndromeOxidative Medicine and Cellular Longevity 2015; 2015: 1 doi: 10.1155/2015/490613
77
Yunxia Dong, Henglei Lu, Qiang Li, Xinming Qi, Yuanchao Li, Zean Zhang, Jing Chen, Jin Ren. (5R)-5-hydroxytriptolide ameliorates liver lipid accumulation by suppressing lipid synthesis and promoting lipid oxidation in miceLife Sciences 2019; 232: 116644 doi: 10.1016/j.lfs.2019.116644
78
Aida Abdeen Mahmoud, Asmaa N. Mohammad, Mohamed Abdel Wahab Ezat. Evaluation of Circulating Fatty Acid Synthase as a Biomarker in Non-Alcoholic Fatty Liver DiseaseOpen Journal of Gastroenterology 2016; 6(09): 229 doi: 10.4236/ojgas.2016.69028